Home > Name List By f > Ferrate(1-),(glycinato-kN,kO)[sulfato(2-)-kO,kO']-, hydrogen (1:1), (T-4)- China

CAS No 17169-60-7 , Ferrate(1-),(glycinato-kN,kO)[sulfato(2-)-kO,kO']-, hydrogen (1:1), (T-4)- Search by region : China

  • Name: Ferrate(1-),(glycinato-kN,kO)[sulfato(2-)-kO,kO']-, hydrogen (1:1), (T-4)-
  • Synonyms: Plesmet; Ferrosanol duodenal; Sulfuric acid, iron complex; Ferronord; Kelferon;Ferrate(1-),(glycinato-kN,kO)[sulfato(2-)-kO,kO']-, hydrogen (1:1), (T-4)-; Orferon retard; Glycine, compd. with iron sulfate (FeSO4)(8CI); Ferroglycine sulfate;Ferrosanol; Glyferro;Ferrate(1-),(glycinato-N,O)[sulfato(2-)-O,O']-, hydrogen, (T-4)-; Pleniron; Ferrate(1-), (glycinato-kN,kO)[sulfato(2-)-kO,kO']-, hydrogen, (T-4)- (9CI);
  • CAS Registry Number:
  • Flash Point: 99.5°C
  • Boiling Point: 240.9°Cat760mmHg
  • Density: g/cm3
  • Safety Statements: Poison by intraperitoneal route. Moderately toxic by ingestion. When heated to decomposition it emits toxic fumes of SOx and NOx.
  • Flash Point: 99.5°C
  • EINECS: 241-221-4
  • Molecular Weight: 226.99
  • InChI: InChI=1/C2H5NO2.Fe.H2O4S/c3-1-2(4)5;;1-5(2,3)4/h1,3H2,(H,4,5);;(H2,1,2,3,4)/q;+2;/p-2
  • Molecular Formula: C2H4 Fe N O6 S . H
  • Molecular Structure:CAS No:17169-60-7 Ferrate(1-),(glycinato-kN,kO)[sulfato(2-)-kO,kO']-, hydrogen (1:1), (T-4)-

Select to

17169-60-7 Ferrous Glycine Sulfate

Contact Supplier

Select to

References of Ferrate(1-),(glycinato-kN,kO)[sulfato(2-)-kO,kO']-, hydrogen (1:1), (T-4)-
Title: Ferroglycine Sulfate
CAS Registry Number: 17169-60-7
CAS Name: (T-4)-Hydrogen (glycinato-kN,kO) [sulfato(2-)-kO,kO¢]-ferrate(1-)
Synonyms: ferrous aminoacetosulfate; iron sulfate-glycine complex
Trademarks: Ferrocontin (Napp); Plesmet (Link); Ferrosanol (Schwarz)
Molecular Formula: C2H5FeNO6S
Molecular Weight: 226.97
Percent Composition: C 10.58%, H 2.22%, Fe 24.60%, N 6.17%, O 42.29%, S 14.13%
Literature References: Chelate of ferrous sulfate and glycine, q.q.v. Prepn: W. Rummell, US 2877253 (1959 to Schwarz Arzneimittelfabrik). Tolerability study: J. Pomeranze, R. J. Gadek, N. Engl. J. Med. 257, 73 (1957). Use in iron fortification of salt: S. Ranganathan et al., Food Chem. 57, 311 (1996). Clinical evaluation in iron deficiency anemia vs ferrous fumarate, q.v.: A. Aronstam, D. L. Aston, Pharmatherapeutica 3, 263 (1982).
Therap-Cat: Hematinic.
Keywords: Hematinic.